Many Canadians have turned to cannabis to ease their anxieties during COVID-19 (as have our American cousins) though precise data about how much remains scarce.
Calgary Herald, Bloomberg,
- You can help fill in the missing data: here’s a short survey on COVID-19 and cannabis use from the Children’s Hospital of Eastern Ontario)
- Law firm McCarthy Tétrault offered a factsheet of legal considerations among COVID’s impacts.
- Neuroscientist and cannabis researcher Nick Jikomes, PhD explained recent research out of the University of Saskatchewan suggesting CBD may prevent COVID.
COVID is one thing, but some believe the industry has yet to recover from last summer’s CannTrust debacle. And surviving COVID doesn’t guarantee companies will come out of the crisis stronger.
Some companies who’ve survived the first three months of the pandemic have done so by employing enormous flexibility and wondering whether the regulators could also be more flexible
- Cannabis NB has allowed licensed cannabis sales through pop-up storefronts at trade shows: whenever we’re able to go to trade shows again, why couldn’t Ontario do the same?
- Provinces could fairly easily update their regs to allow for nurseries to sell seeds and clones direct to consumers online.
- Ottawa’s Hybrid Pharma, the first pharmacy outside Shoppers Drug Mart to secure a Health Canada sales license for MED, is pushing for Health Canada to harmonize the MED system with the Canadian pharmacy system to allow for in-patient consultations.